Next Article in Journal / Special Issue
Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective
Previous Article in Journal
Predictors and Barriers to Full Vaccination among Children in Ethiopia
Previous Article in Special Issue
New Kids on the Block: RNA-Based Influenza Virus Vaccines
Review

“Gnothi Seauton”: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy

Michael G. DeGroote Institute for Infectious Diseases Research, McMaster Immunology Research Centre, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4K1, Canada
*
Author to whom correspondence should be addressed.
These authors contributed equally.
Vaccines 2018, 6(2), 23; https://doi.org/10.3390/vaccines6020023
Received: 2 March 2018 / Revised: 9 April 2018 / Accepted: 10 April 2018 / Published: 12 April 2018
Vaccination against the seasonal influenza virus is the best way to prevent infection. Nevertheless, vaccine efficacy remains far from optimal especially in high-risk populations such as the elderly. Recent technological advancements have facilitated rapid and precise identification of the B and T cell epitopes that are targets for protective responses. While these discoveries have undoubtedly brought the field closer to “universal” influenza virus vaccines, choosing the correct antigen is only one piece of the equation. Achieving efficacy and durability requires a detailed understanding of the diverse host factors and pathways that are required for attaining optimal responses. Sequencing technologies, systems biology, and immunological studies have recently advanced our understanding of the diverse aspects of the host response required for vaccine efficacy. In this paper, we review the critical role of the host response in determining efficacious responses and discuss the gaps in knowledge that will need to be addressed if the field is to be successful in developing new and more effective influenza virus vaccines. View Full-Text
Keywords: influenza virus; vaccines; host factors; systems biology; polymorphisms; dendritic cells; adjuvants; innate immunity; adaptive immunity influenza virus; vaccines; host factors; systems biology; polymorphisms; dendritic cells; adjuvants; innate immunity; adaptive immunity
Show Figures

Figure 1

MDPI and ACS Style

Stacey, H.D.; Barjesteh, N.; Mapletoft, J.P.; Miller, M.S. “Gnothi Seauton”: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy. Vaccines 2018, 6, 23. https://doi.org/10.3390/vaccines6020023

AMA Style

Stacey HD, Barjesteh N, Mapletoft JP, Miller MS. “Gnothi Seauton”: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy. Vaccines. 2018; 6(2):23. https://doi.org/10.3390/vaccines6020023

Chicago/Turabian Style

Stacey, Hannah D., Neda Barjesteh, Jonathan P. Mapletoft, and Matthew S. Miller. 2018. "“Gnothi Seauton”: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy" Vaccines 6, no. 2: 23. https://doi.org/10.3390/vaccines6020023

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop